Glioblastoma Multiforme
Conditions
Keywords
glioblastoma multiforme
Brief summary
Clinical research can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in glioblastoma multiforme clinical study, as well as the reasons for withdrawal or discontinuation. Insights gained from this study will ultimately benefit those with glioblastoma multiforme who may be invited to participate in clinical trial in the years to come.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of glioblastoma multiforme * No prior treatment for glioblastoma multiforme * Ability to understand and the willingness to sign a written informed consent document.
Exclusion criteria
* Female patients who are currently pregnant or nursing * Enrolled in another research study * Patients who are currently receiving any other investigational drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to enroll in a glioblastoma multiforme clinical study. | 3 months |
| Number of glioblastoma multiforme study participants who remain in clinical trial until completion. | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed